z-logo
Premium
Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC‐MS/MS
Author(s) -
AlDirbashi Osama Y.,
Rashed Mohamed S.,
Jacob Minnie,
AlAhaideb Lujane Y.,
AlAmoudi Mohamed,
Rahbeeni Zuhair,
AlSayed Moeen M.,
AlHassnan Zuhair,
AlOwain Mohamed,
AlZeidan Hamad
Publication year - 2008
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.1049
Subject(s) - chemistry , chromatography , dried blood , tyrosinemia , spots , biochemistry , tyrosine
We describe an improved diagnostic method for tyrosinemia type 1 based on quantifying succinylacetone in dried blood spots by ultra‐performance liquid chromatography tandem mass spectrometry. Succinylacetone extracted from a single 3/16 inch disk of specimen collection paper containing a dried blood spot was derivatized with dansylhydrazine, separated on an Acquity UPLC BEH C 18 column (2.1 × 50 mm, 1.7 µm) and detected by electrospray ionization tandem mass spectrometry. Succinylacetone derivative eluted at 0.6 min with a complete run time of 1 min. Using a 13 C 4 labeled succinylacetone as an internal standard, the calibration plot was linear up to 100 µmol/L with a detection limit (S/N = 3) of 0.2 µmol/L. Intra‐day ( n = 13) and inter‐day ( n = 10) variations were better than 10%. The cutoff level of succinylacetone in dried blood spots from healthy infants obtained by the current method was 0.63 µmol/L ( n = 151). In dried blood spots from patients with established tyrosinemia type 1 ( n = 11), concentration of succinylacetone was 6.4–30.8 µmol/L. Copyright © 2008 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom